OrbiMed Advisors Israel II Ltd, 10% Owner at 89bio, Inc. (ETNB), sold 116,601 shares at $8.38 ($979K) on 2022-01-26, disclosed to the SEC on 2022-01-27.
Open-market sale of $979k ETNB by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.40 | 24,545 | $206K | 21.1% |
| 2 | $8.40 | 24,546 | $206K | 21.1% |
| 3 | $8.40 | 24,546 | $206K | 21.1% |
| 4 | $8.38 | 10,740 | $90K | 9.2% |
| 5 | $8.38 | 10,740 | $90K | 9.2% |
| 6 | $8.38 | 10,742 |
| $90K |
| 9.2% |
| 7 | $8.38 | 10,742 | $90K | 9.2% |
| Total | $8.39 avg | 116,601 | $979K | 100% |
| Filing → |
| GLTO | SELL | 2023-07-17 | $467K | — | Filing → |
| GLTO | SELL | 2023-04-12 | $184K | — | Filing → |
| ETNB | BUY | 2019-11-13 | $6.7M | — | Filing → |